Products

LuciPral is used in RET fusion-positive lung and thyroid cancers. It is a targeted therapy used globally. Active Ingredient Pralsetinib inhibits RET kinase activity. Uses of LuciPral • RET-positive NSCLC • Thyroid cancer How LuciPral Works Blocks RET signaling pathways involved in tumor growth. How to Use LuciPral • Take on empty stomach Possible Side Effects • Hypertension • Fatigue Precautions • Monitor blood pressure Safety Information Use under supervision. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children

LuciGil is used to treat relapsed or refractory acute myeloid leukemia with FLT3 mutation. Active Ingredient Gilteritinib inhibits FLT3 receptor signaling. Uses of LuciGil • FLT3-positive AML How LuciGil Works It blocks FLT3 pathways responsible for cancer cell proliferation. How to Use LuciGil • Take once daily Possible Side Effects • Fatigue • Elevated liver enzymes Precautions • Monitor heart rhythm • Regular blood tests Safety Information Use under medical supervision. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children

LuciPem is indicated for the treatment of bile duct cancer with FGFR gene alterations. It is a precision oncology medicine used globally. Active Ingredient Pemigatinib inhibits fibroblast growth factor receptors (FGFR). Uses of LuciPem • Cholangiocarcinoma with FGFR mutation How LuciPem Works It blocks FGFR signaling pathways involved in tumor growth. How to Use LuciPem • Take as prescribed in cycles Possible Side Effects • Hyperphosphatemia • Fatigue • Dry mouth Precautions • Monitor phosphate levels • Eye exams recommended Safety Information Regular monitoring required. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children

Lucivos is used in the treatment of acute myeloid leukemia (AML) with IDH1 mutation. It is a targeted therapy designed to improve outcomes in specific genetic cancer types. Active Ingredient Ivosidenib inhibits mutated IDH1 enzyme, restoring normal cell differentiation. Uses of Lucivos • Acute myeloid leukemia (IDH1 mutation) How Lucivos Works It blocks abnormal IDH1 enzyme activity, helping immature blood cells mature normally. How to Use Lucivos • Take once daily • Follow doctor’s instructions Possible Side Effects • Fatigue • Diarrhea • Joint pain Precautions • Monitor heart rhythm • Regular blood tests required Safety Information Use under strict medical supervision. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children

LuciFine contains finerenone, a non-steroidal mineralocorticoid receptor antagonist used to treat chronic kidney disease (CKD) associated with type 2 diabetes. It is widely used to reduce the risk of kidney function decline and cardiovascular complications. Active Ingredient Finerenone blocks mineralocorticoid receptors, reducing inflammation and fibrosis in the kidneys and heart. Uses of LuciFine • Chronic kidney disease in type 2 diabetes • Reduction of cardiovascular risk How LuciFine Works It inhibits overactivation of mineralocorticoid receptors, preventing damage to kidney tissues and reducing inflammation. How to Use LuciFine • Take once daily as prescribed • With or without food Possible Side Effects • Hyperkalemia • Low blood pressure • Dizziness Precautions • Monitor potassium levels • Avoid potassium supplements Safety Information Regular blood tests are required during treatment. Storage • Store at room temperature • Protect from moisture and sunlight • Keep out of reach of children

LuciLorla is used in advanced ALK-positive lung cancer, especially after other treatments fail. Active Ingredient Lorlatinib is a third-generation ALK inhibitor. Uses of LuciLorla • ALK-positive NSCLC How LuciLorla Works Blocks ALK mutations and resistance pathways. How to Use LuciLorla • Take once daily Possible Side Effects • Weight gain • Mood changes Precautions • Monitor cholesterol Safety Information Use under supervision. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children

LuciLorla is used in advanced ALK-positive lung cancer, especially after other treatments fail. Active Ingredient Lorlatinib is a third-generation ALK inhibitor. Uses of LuciLorla • ALK-positive NSCLC How LuciLorla Works Blocks ALK mutations and resistance pathways. How to Use LuciLorla • Take once daily Possible Side Effects • Weight gain • Mood changes Precautions • Monitor cholesterol Safety Information Use under supervision. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children

LuciAvat is used to increase platelet counts in patients with thrombocytopenia. Active Ingredient Avatrombopag stimulates platelet production. Uses of LuciAvat • Chronic liver disease thrombocytopenia How LuciAvat Works Activates thrombopoietin receptors to increase platelets. How to Use LuciAvat • Take as directed Possible Side Effects • Headache • Fatigue Precautions • Monitor platelet count Safety Information Doctor supervision required. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children

LuciCriz is used in ALK-positive lung cancer patients. It helps control tumor growth. Active Ingredient Crizotinib inhibits ALK and ROS1 proteins. Uses of LuciCriz • ALK-positive NSCLC • ROS1-positive lung cancer How LuciCriz Works Blocks signals responsible for cancer cell proliferation. How to Use LuciCriz • Take as prescribed Possible Side Effects • Vision changes • Nausea Precautions • Monitor liver and heart Safety Information Use under supervision. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children

Lucisot is used for treating KRAS G12C mutation-positive lung cancer. It is a precision medicine approach in oncology. Active Ingredient Sotorasib inhibits KRAS G12C protein. Uses of Lucisot • KRAS-mutated NSCLC How Lucisot Works It blocks abnormal KRAS signaling, reducing tumor growth. How to Use Lucisot • Take once daily Possible Side Effects • Diarrhea • Fatigue Precautions • Monitor liver function Safety Information Use under medical supervision. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children

LuciOsim is used in treating EGFR mutation-positive non-small cell lung cancer. It is widely used for advanced stages. Active Ingredient Osimertinib is an EGFR tyrosine kinase inhibitor. Uses of LuciOsim • EGFR-positive NSCLC • Metastatic lung cancer How LuciOsim Works It blocks EGFR mutations responsible for cancer cell growth. How to Use LuciOsim • Take once daily • With or without food Possible Side Effects • Diarrhea • Rash • Nail toxicity Precautions • Monitor heart and lungs • Avoid pregnancy Safety Information Requires regular monitoring. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children

LuciElo is used to treat low platelet counts in conditions like immune thrombocytopenia. It helps reduce bleeding risk. Active Ingredient Eltrombopag stimulates thrombopoietin receptors to increase platelet production. Uses of LuciElo • Immune thrombocytopenia • Chronic liver disease-related thrombocytopenia How LuciElo Works It promotes platelet production in bone marrow by activating thrombopoietin receptors. How to Use LuciElo • Take on empty stomach • Avoid dairy products around dosing time Possible Side Effects • Headache • Nausea • Liver enzyme changes Precautions • Monitor liver function • Avoid excessive calcium intake Safety Information Use under doctor supervision with regular blood tests. Storage • Store at room temperature • Keep away from moisture • Keep out of reach of children